Outlook Therapeutics raises $13M in public offering of common stock and warrants

Outlook Therapeutics, Inc.

Offering of 9,285,714 shares and warrants to purchase 18,571,428 shares at combined price $1.40 per unit.
Gross proceeds of ~$13M; closing expected May 27, 2025.
Warrants exercisable immediately at $1.40/share, expire in 5 years, with beneficial ownership cap.
GMS Ventures (affiliated with directors) committed $6M of the offering.
Underwriting agreement entered with BTIG, LLC.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.